The 2011–2020 Trends of Data-Driven Approaches in Medical Informatics for Active Pharmacovigilance
Open Access
- 4 March 2021
- journal article
- review article
- Published by MDPI AG in Applied Sciences
- Vol. 11 (5), 2249
- https://doi.org/10.3390/app11052249
Abstract
Pharmacovigilance, the scientific discipline pertaining to drug safety, has been studied extensively and is progressing continuously. In this field, medical informatics techniques and interpretation play important roles, and appropriate approaches are required. In this study, we investigated and analyzed the trends of pharmacovigilance systems, especially the data collection, detection, assessment, and monitoring processes. We used PubMed to collect papers on pharmacovigilance published over the past 10 years, and analyzed a total of 40 significant papers to determine the characteristics of the databases and data analysis methods used to identify drug safety indicators. Through systematic reviews, we identified the difficulty of standardizing data and terminology and establishing an adverse drug reactions (ADR) evaluation system in pharmacovigilance, and their corresponding implications. We found that appropriate methods and guidelines for active pharmacovigilance using medical big data are still required and should continue to be developed.Funding Information
- National Research Foundation of Korea (2018R1D1A1B07049155)
This publication has 69 references indexed in Scilit:
- Large-scale combining signals from both biomedical literature and the FDA Adverse Event Reporting System (FAERS) to improve post-marketing drug safety signal detectionBMC Bioinformatics, 2014
- Comparative analysis of pharmacovigilance methods in the detection of adverse drug reactions using electronic medical recordsJournal of the American Medical Informatics Association, 2013
- Follow-Up Study of a Pharmacovigilance SignalJournal of Clinical Psychopharmacology, 2012
- Safety of Attention-Deficit/Hyperactivity Disorder Medications in Children: An Intensive Pharmacosurveillance Monitoring StudyJournal of Child and Adolescent Psychopharmacology, 2012
- Study of Natural Health Product Adverse Reactions (SONAR): Active Surveillance of Adverse Events Following Concurrent Natural Health Product and Prescription Drug Use in Community PharmaciesPLOS ONE, 2012
- Representativeness of diabetes patients participating in a web‐based adverse drug reaction monitoring systemPharmacoepidemiology and Drug Safety, 2012
- Enhancing Adverse Drug Event Detection in Electronic Health Records Using Molecular Structure Similarity: Application to PancreatitisPLOS ONE, 2012
- Drugs and dilated cardiomyopathies: a case/noncase study in the French PharmacoVigilance DatabaseBritish Journal of Clinical Pharmacology, 2010
- The New Sentinel Network — Improving the Evidence of Medical-Product SafetyThe New England Journal of Medicine, 2009
- Informatic Tools and Approaches in Postmarketing Pharmacovigilance Used by FDAThe AAPS Journal, 2008